Bristol Myers wins latest test for Krazati (NYSE:BMY)
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its FDA-cleared cancer therapy Krazati (adagrasib), ...
Tag: NYSEBMY
Pharma and Biotech Deal Values Jump 35% in 2023 (NYSE:BMY)
NISIT RAWO/iStock via Getty Images Pharma and biotech deal values rose 35% in 2023, as major drugmakers face patent cliffs ...
Recommended.
